Education
About Us
Working with TipRanks
Follow Us
Grace Therapeutics (GRCE)
NASDAQ:GRCE
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 196.00K |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 120.00K |
| Operating Income | $ 0.00 | $ -12.85M | $ -52.16M | $ -15.59M | $ -16.42M |
| EBITDA | $ 0.00 | $ -11.33M | $ -18.12M | $ -15.34M | $ -9.79M |
| Net Income | $ -12.77M | $ -12.85M | $ -42.43M | $ -9.82M | $ -19.68M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 22.13M | $ 23.00M | $ 27.89M | $ 43.66M | $ 60.73M |
| Total Assets | $ 71.99M | $ 73.30M | $ 79.12M | $ 128.62M | $ 62.46M |
| Total Debt | $ 0.00 | $ 0.00 | $ 485.00K | $ 295.00K | $ 86.00K |
| Net Debt | $ -22.13M | $ -23.00M | $ -27.39M | $ -30.04M | $ -50.86M |
| Total Liabilities | $ 5.38M | $ 11.56M | $ 11.17M | $ 20.35M | $ 6.80M |
| Stockholders' Equity | $ 66.61M | $ 61.74M | $ 67.95M | $ 108.27M | $ 55.66M |
| Cash Flow | |||||
| Free Cash Flow | $ -14.90M | $ -12.36M | $ -15.93M | $ -17.23M | $ -14.39M |
| Operating Cash Flow | $ -14.90M | $ -12.33M | $ -15.91M | $ -17.23M | $ -14.32M |
| Investing Cash Flow | $ 0.00 | $ 104.00K | $ 13.15M | $ -3.52M | $ -9.86M |
| Financing Cash Flow | $ 14.03M | $ 7.36M | $ 304.00K | $ 0.00 | $ 59.49M |